The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
DNA Methylation Cancer Biomarkers: Translation to the Clinic
Open accessAbstract
Carcinogenesis is accompanied by widespread DNA methylation changes within the cell. These changes are characterised by a globally hypomethylated genome with focal hypermethylation of numerous 5'-cytosine-phosphate-guanine-3' (CpG) islands, often spanning gene promoters and first exons. Many of these epigenetic changes occur early in tumorigenesis and are highly pervasive across a tumour type. This allows DNA methylation cancer biomarkers to be suitable for early detection and also to have utility across a range of areas relevant to cancer detection and treatment. Such tests are also simple in construction, as only one or a few loci need to be targeted for good test coverage. These properties make cancer-associated DNA methylation changes very attractive for development of cancer biomarker tests with substantive clinical utility. Across the patient journey from initial detection, to treatment and then monitoring, there are several points where DNA methylation assays can inform clinical practice. Assays on surgically removed tumour tissue are useful to determine indicators of treatment resistance, prognostication of outcome or to molecularly characterise, classify and determine the tissue of origin of a tumour. Cancer-associated DNA methylation changes can also be detected with accuracy in the cell-free DNA present in blood, stool, urine and other biosamples. Such tests hold great promise for the development of simple, economical and highly specific cancer detection tests suitable for population-wide screening, with several successfully translated examples already. The ability of circulating tumour DNA liquid biopsy assays to monitor cancer in situ also allows for the ability to monitor response to therapy, to detect minimal residual disease and as an early biomarker for cancer recurrence. This review will summarise existing DNA methylation cancer biomarkers used in clinical practice across the application domains above, discuss what makes a suitable DNA methylation cancer biomarker and identify barriers to translation. We discuss technical factors such as the analytical performance and product-market fit, factors that contribute to successful downstream investment, including geography, and how this impacts intellectual property (IP), regulatory hurdles and the future of the marketplace and healthcare system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,657
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
Human DNA methylomes at base resolution show widespread epigenomic differences
Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D., Hon, G., Tonti-Filippini, J., Nery, J. R., Lee, L., Ye, Z., Ngo, Q.-M., et al. (2009) · Nature · doi:10.1038/nature08514 · Cited by 4,673
Tumour heterogeneity and resistance to cancer therapies
Dagogo-Jack, I., & Shaw, A. T. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.166 · Cited by 3,846
Frommer, M., McDonald, L. E., Millar, D. S., Collis, C. M., Watt, F., Grigg, G. W., Molloy, P. L., & Paul, C. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1827 · Cited by 3,238
DNA methylation-based classification of central nervous system tumours
Capper, D., Jones, D. T. W., Sill, M., Hovestadt, V., Schrimpf, D., Sturm, D., Koelsche, C., Sahm, F., Chavez, L., Reuss, D. E., et al. (2018) · Nature · doi:10.1038/nature26000 · Cited by 3,033
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Cohen, J. D., Li, L., Wang, Y., Thoburn, C., Afsari, B., Danilova, L., Douville, C., Javed, A. A., Wong, F., Mattox, A., et al. (2018) · Science · doi:10.1126/science.aar3247 · Cited by 2,783
Hoadley, K. A., Yau, C., Hinoue, T., Wolf, D. M., Lazar, A. J., Drill, E., Shen, R., Taylor, A. M., Cherniack, A. D., Thorsson, V., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.022 · Cited by 2,546
Inactivation of the DNA-Repair Gene MGMT and the Clinical Response of Gliomas to Alkylating Agents
Esteller, M., Garcia-Foncillas, J., Andion, E., Goodman, S. N., Hidalgo, O. F., Vanaclocha, V., Baylin, S. B., & Herman, J. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431901 · Cited by 2,224
Multitarget Stool DNA Testing for Colorectal-Cancer Screening
Imperiale, T. F., Ransohoff, D. F., Itzkowitz, S. H., Levin, T. R., Lavin, P., Lidgard, G. P., Ahlquist, D. A., & Berger, B. M. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311194 · Cited by 1,900
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
Herman, J. G., Umar, A., Polyak, K., Graff, J. R., Ahuja, N., Issa, J.-P. J., Markowitz, S., Willson, J. K. V., Hamilton, S. R., Kinzler, K. W., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6870 · Cited by 1,887
High sensitivity mapping of methylated cytosines
Susan, J. C., Harrison, J., Paul, C. L., & Frommer, M. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.15.2990 · Cited by 1,862
The epigenetic progenitor origin of human cancer
Feinberg, A. P., Ohlsson, R., & Henikoff, S. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1748 · Cited by 1,853
Weber, M., Davies, J. J., Wittig, D., Oakeley, E. J., Haase, M., Lam, W. L., & Schübeler, D. (2005) · Nature Genetics · doi:10.1038/ng1598 · Cited by 1,754
High density DNA methylation array with single CpG site resolution
Bibikova, M., Barnes, B., Tsan, C., Ho, V., Klotzle, B., Le, J. M., Delano, D., Zhang, L., Schroth, G. P., Gunderson, K. L., et al. (2011) · Genomics · doi:10.1016/j.ygeno.2011.07.007 · Cited by 1,727 · cited 1×
“PSA has a reported specificity of 91% and sensitivity of 21% for primary diagnosis of prostate cancer (with cut-off value of 4 ng/ml) (Brawer et al., 1992; Catalona, 1993).”
BackgroundA Sequencing Method Based on Real-Time Pyrophosphate
Ronaghi, M., Uhlén, M., & Nyrén, P. (1998) · Science · doi:10.1126/science.281.5375.363 · Cited by 1,630
Kulis, M., & Esteller, M. (2010) · Advances in Genetics · doi:10.1016/b978-0-12-380866-0.60002-2 · Cited by 1,566
Induction of tumors in mice by genomic hypomethylation
Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083558 · Cited by 1,499
Pidsley, R., Zotenko, E., Peters, T. J., Lawrence, M. G., Risbridger, G. P., Molloy, P., Van Djik, S., Muhlhausler, B., Stirzaker, C., & Clark, S. J. (2016) · Genome biology · doi:10.1186/s13059-016-1066-1 · Cited by 1,480
Genome-wide cell-free DNA fragmentation in patients with cancer
Cristiano, S., Leal, A., Phallen, J., Fiksel, J., Adleff, V., Bruhm, D. C., Jensen, S. Ø., Medina, J. E., Hruban, C., White, J. R., et al. (2019) · Nature · doi:10.1038/s41586-019-1272-6 · Cited by 1,476
Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin
Snyder, M. W., Kircher, M., Hill, A. J., Daza, R. M., & Shendure, J. (2016) · Cell · doi:10.1016/j.cell.2015.11.050 · Cited by 1,464
MethyLight: a high-throughput assay to measure DNA methylation
Eads, C. A. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.8.e32 · Cited by 1,424
High-Resolution Genotyping by Amplicon Melting Analysis Using LCGreen
Wittwer, C. T., Reed, G. H., Gundry, C. N., Vandersteen, J. G., & Pryor, R. J. (2003) · Clinical Chemistry · doi:10.1373/49.6.853 · Cited by 1,257
Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis
Meissner, A. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki901 · Cited by 1,217
COBRA: a sensitive and quantitative DNA methylation assay
Xiong, Z., & Laird, P. W. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.12.2532 · Cited by 1,195
Detecting DNA cytosine methylation using nanopore sequencing
Simpson, J. T., Workman, R. E., Zuzarte, P. C., David, M., Dursi, L. J., & Timp, W. (2017) · Nature Methods · doi:10.1038/nmeth.4184 · Cited by 1,136
Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells
Ball, M. P., Li, J. B., Gao, Y., Lee, J.-H., LeProust, E. M., Park, I.-H., Xie, B., Daley, G. Q., & Church, G. M. (2009) · Nature Biotechnology · doi:10.1038/nbt.1533 · Cited by 1,093
Establishing the Diagnosis of Lung Cancer
Rivera, M. P., Mehta, A. C., & Wahidi, M. M. (2013) · Chest · doi:10.1378/chest.12-2353 · Cited by 1,089
Jacobs, I. J., Menon, U., Ryan, A., Gentry-Maharaj, A., Burnell, M., Kalsi, J. K., Amso, N. N., Apostolidou, S., Benjamin, E., Cruickshank, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01224-6 · Cited by 1,048 · cited 1×
“…BCAT1 and IKZF1 are hypermethylated in 97.8% and 86.8% of CRC tumor biopsies, respectively; yet, the ability to detect ctDNA using the same assay vary by staging, tumor size, location, and lymphatic invasion (Pedersen et al., 2015a; Symonds et al., 2016; Jedi et al., 2018; Symonds et al., 2018).”
BackgroundInfluentialMoss, J., Magenheim, J., Neiman, D., Zemmour, H., Loyfer, N., Korach, A., Samet, Y., Maoz, M., Druid, H., Arner, P., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07466-6 · Cited by 1,012
Catalona, W. J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510080052031 · Cited by 998
Sawyers, C. L. (2008) · Nature · doi:10.1038/nature06913 · Cited by 983
Belinsky, S. A., Nikula, K. J., Palmisano, W. A., Michels, R., Saccomanno, G., Gabrielson, E., Baylin, S. B., & Herman, J. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11891 · Cited by 956
Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
Volkova, M., & Russell, R. (2012) · Current Cardiology Reviews · doi:10.2174/157340311799960645 · Cited by 872
Ehrich, M., Nelson, M. R., Stanssens, P., Zabeau, M., Liloglou, T., Xinarianos, G., Cantor, C. R., Field, J. K., & van den Boom, D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507816102 · Cited by 812
Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer
Church, T. R., Wandell, M., Lofton-Day, C., Mongin, S. J., Burger, M., Payne, S. R., Castaños-Vélez, E., Blumenstein, B. A., Rösch, T., Osborn, N., et al. (2014) · Gut · doi:10.1136/gutjnl-2012-304149 · Cited by 796
Padlock Probes: Circularizing Oligonucleotides for Localized DNA Detection
Nilsson, M., Malmgren, H., Samiotaki, M., Kwiatkowski, M., Chowdhary, B. P., & Landegren, U. (1994) · Science · doi:10.1126/science.7522346 · Cited by 791
Bisulfite genomic sequencing: systematic investigation of critical experimental parameters
Grunau, C. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.13.e65 · Cited by 789
The Behaviour of 5-Hydroxymethylcytosine in Bisulfite Sequencing
Huang, Y., Pastor, W. A., Shen, Y., Tahiliani, M., Liu, D. R., & Rao, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008888 · Cited by 717
A European Respiratory Society technical standard: exhaled biomarkers in lung disease
Horváth, I., Barnes, P. J., Loukides, S., Sterk, P. J., Högman, M., Olin, A.-C., Amann, A., Antus, B., Baraldi, E., Bikov, A., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00965-2016 · Cited by 638
Screening for Prostatic Carcinoma with Prostate Specific Antigen
Brawer, M. K., CHETNER, M. P., Beatie, J., Büchner, D. M., Vessella, R. L., & Lange, P. H. (1992) · The Journal of Urology · doi:10.1016/s0022-5347(17)37401-3 · Cited by 612
Cancer of unknown primary site
Pavlidis, N., & Pentheroudakis, G. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61178-1 · Cited by 584
Cohen, J. D., Javed, A. A., Thoburn, C., Wong, F., Tie, J., Gibbs, P., Schmidt, C. M., Yip-Schneider, M. T., Allen, P. J., Schattner, M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704961114 · Cited by 582
MGMT testing—the challenges for biomarker-based glioma treatment
Wick, W., Weller, M., van den Bent, M., Sanson, M., Weiler, M., von Deimling, A., Plass, C., Hegi, M., Platten, M., & Reifenberger, G. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.100 · Cited by 579
Wojdacz, T. K., & Dobrovic, A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm013 · Cited by 551
Anderson, J. L., Heidenreich, P. A., Barnett, P. G., Creager, M. A., Fonarow, G. C., Gibbons, R. J., Halperin, J. L., Hlatky, M. A., Jacobs, A. K., Mark, D. B., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000042 · Cited by 519
Mapping DNA methylation with high-throughput nanopore sequencing
Rand, A. C., Jain, M., Eizenga, J. M., Musselman-Brown, A., Olsen, H. E., Akeson, M., & Paten, B. (2017) · Nature Methods · doi:10.1038/nmeth.4189 · Cited by 507
Deng, J., Shoemaker, R., Xie, B., Gore, A., LeProust, E. M., Antosiewicz-Bourget, J., Egli, D., Maherali, N., Park, I.-H., Yu, J., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1530 · Cited by 491
Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis
Moran, S., Martínez-Cardús, A., Sayols, S., Musulén, E., Balañá, C., Estival-Gonzalez, A., Moutinho, C., Heyn, H., Diaz-Lagares, A., de Moura, M. C., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30297-2 · Cited by 484
Bisulfite-free direct detection of 5-methylcytosine and 5-hydroxymethylcytosine at base resolution
Liu, Y., Siejka-Zielińska, P., Velikova, G., Bi, Y., Yuan, F., Tomkova, M., Bai, C., Chen, L., Schuster-Böckler, B., & Song, C.-X. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0041-2 · Cited by 472
DNA methylation markers for diagnosis and prognosis of common cancers
Hao, X., Luo, H., Krawczyk, M., Wei, W., Wang, W., Wang, J., Flagg, K., Hou, J., Zhang, H., Yi, S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1703577114 · Cited by 458
Fizazi, K., Greco, F. A., Pavlidis, N., Daugaard, G., Oien, K., & Pentheroudakis, G. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv305 · Cited by 453
Inferring expressed genes by whole-genome sequencing of plasma DNA
Ulz, P., Thallinger, G. G., Auer, M., Graf, R., Kashofer, K., Jahn, S. W., Abete, L., Pristauz, G., Petru, E., Geigl, J. B., et al. (2016) · Nature Genetics · doi:10.1038/ng.3648 · Cited by 441
ACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance Measures
Anderson, J. L., Heidenreich, P. A., Barnett, P. G., Creager, M. A., Fonarow, G. C., Gibbons, R. J., Halperin, J. L., Hlatky, M. A., Jacobs, A. K., Mark, D. B., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.016 · Cited by 441
Ali, H., Donovan, B., Wand, H., Read, T. R. H., Regan, D. G., Grulich, A. E., Fairley, C. K., & Guy, R. J. (2013) · BMJ · doi:10.1136/bmj.f2032 · Cited by 426
DNA Methylation: A Profile of Methods and Applications
Fraga, M. F., & Esteller, M. (2002) · BioTechniques · doi:10.2144/02333rv01 · Cited by 422
Carcinoembryonic Antigen in the Staging and Follow-up of Patients with Colorectal Cancer
Goldstein, M. J., & Mitchell, E. P. (2005) · Cancer Investigation · doi:10.1081/cnv-58878 · Cited by 419
Whole genome sequencing analysis for cancer genomics and precision medicine
Nakagawa, H., & Fujita, M. (2018) · Cancer Science · doi:10.1111/cas.13505 · Cited by 375
Clinical utility of biochemical markers in colorectal cancer
Duffy, M. J., van Dalen, A., Haglund, C., Hansson, L., Klapdor, R., Lamerz, R., Nilsson, O., Sturgeon, C., & Topolcan, O. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00811-0 · Cited by 374
Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management
Elazezy, M., & Joosse, S. A. (2018) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2018.10.002 · Cited by 370
Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia.
Esteller, M., Corn, P. G., Ureña, J. M., Gabrielson, E. W., Baylin, S. B., & Herman, J. G. (1998) · PubMed · Cited by 356
Lawn, S. D., Kerkhoff, A. D., Vogt, M., & Wood, R. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70251-1 · Cited by 300
Daskalos, A., Nikolaidis, G., Xinarianos, G., Savvari, P., Cassidy, A., Zakopoulou, R., Kotsinas, A., Gorgoulis, V., Field, J. K., & Liloglou, T. (2009) · International Journal of Cancer · doi:10.1002/ijc.23849 · Cited by 290
Potter, N. T., Hurban, P., White, M. N., Whitlock, K. D., Lofton-Day, C. E., Tetzner, R., Koenig, T., Quigley, N. B., & Weiss, G. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2013.221044 · Cited by 289
Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum
Hulbert, A., Jusue-Torres, I., Stark, A., Chen, C., Rodgers, K., Lee, B., Griffin, C., Yang, A., Huang, P., Wrangle, J., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1371 · Cited by 275
Liang, W., Zhao, Y., Huang, W., Gao, Y., Xu, W., Tao, J., Yang, M., Li, L., Ping, W., Shen, H., et al. (2019) · Theranostics · doi:10.7150/thno.28119 · Cited by 265
Guidelines for the Preanalytical Conditions for Analyzing Circulating Cell-Free DNA
Meddeb, R., Pisareva, E., & Thierry, A. R. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2018.298323 · Cited by 262
Cancer of Unknown Primary Site
Varadhachary, G. R., & Raber, M. N. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1303917 · Cited by 261
Kang, S., Li, Q., Chen, Q., Zhou, Y., Park, S., Lee, G., Grimes, B., Krysan, K., Yu, M., Wang, W., et al. (2017) · Genome Biology · doi:10.1186/s13059-017-1191-5 · Cited by 255
DeepSignal: detecting DNA methylation state from Nanopore sequencing reads using deep-learning
Ni, P., Huang, N., Zhang, Z., Wang, D.-P., Liang, F., Miao, Y., Xiao, C.-L., Luo, F., & Wang, J. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz276 · Cited by 252
Read, T. R. H., Hocking, J. S., Chen, M. Y., Donovan, B., Bradshaw, C. S., & Fairley, C. K. (2011) · Sexually Transmitted Infections · doi:10.1136/sextrans-2011-050234 · Cited by 249
Adler, A., Geiger, S., Keil, A., Bias, H., Schatz, P., deVos, T., Dhein, J., Zimmermann, M., Tauber, R., & Wiedenmann, B. (2014) · BMC Gastroenterology · doi:10.1186/1471-230x-14-183 · Cited by 229
Epigenetic Cross-Talk between DNA Methylation and Histone Modifications in Human Cancers
Kondo, Y. (2009) · Yonsei Medical Journal · doi:10.3349/ymj.2009.50.4.455 · Cited by 223
Weiss, G., Schlegel, A., Kottwitz, D., König, T., & Tetzner, R. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.08.123 · Cited by 188
Urine Markers for Detection and Surveillance of Non–Muscle-Invasive Bladder Cancer
Tilki, D., Burger, M., Dalbagni, G., Grossman, H. B., Hakenberg, O. W., Palou, J., Reich, O., Rouprêt, M., Shariat, S. F., & Zlotta, A. R. (2011) · European Urology · doi:10.1016/j.eururo.2011.05.053 · Cited by 186
Nechvatal, J. M., Ram, J. L., Basson, M. D., Namprachan, P., Niec, S. R., Badsha, K. Z., Matherly, L. H., Majumdar, A. P. N., & Kato, I. (2008) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2007.11.007 · Cited by 173
Sina, A. A. I., Carrascosa, L. G., Liang, Z., Grewal, Y. S., Wardiana, A., Shiddiky, M. J. A., Gardiner, R. A., Samaratunga, H., Gandhi, M. K., Scott, R. J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07214-w · Cited by 172
Tao, Y., Kang, B., Petkovich, D. A., Bhandari, Y. R., In, J., Stein-O'Brien, G., Kong, X., Xie, W., Zachos, N., Maegawa, S., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.005 · Cited by 170
The Stool DNA Test Is More Accurate Than the Plasma Septin 9 Test in Detecting Colorectal Neoplasia
Ahlquist, D. A., Taylor, W. R., Mahoney, D. W., Zou, H., Domanico, M., Thibodeau, S. N., Boardman, L. A., Berger, B. M., & Lidgard, G. P. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.10.008 · Cited by 166
A panel of genes methylated with high frequency in colorectal cancer
Mitchell, S. M., Ross, J. P., Drew, H. R., Ho, T., Brown, G. S., Saunders, N. F., Duesing, K. R., Buckley, M. J., Dunne, R., Beetson, I., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-54 · Cited by 164
Self-citationInternational Organization for Standardization (ISO) 15189
Schneider, F., Maurer, C., & Friedberg, R. C. (2017) · Annals of Laboratory Medicine · doi:10.3343/alm.2017.37.5.365 · Cited by 164
Oussalah, A., Rischer, S., Bensenane, M., Conroy, G., Filhine-Tresarrieu, P., Debard, R., Forest-Tramoy, D., Josse, T., Reinicke, D., Garcia, M., et al. (2018) · eBioMedicine · doi:10.1016/j.ebiom.2018.03.029 · Cited by 164
The nasal methylome and childhood atopic asthma
Yang, I. V., Pedersen, B. S., Liu, A. H., O'Connor, G. T., Pillai, D., Kattan, M., Misiak, R. T., Gruchalla, R., Szefler, S. J., Khurana Hershey, G. K., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.07.036 · Cited by 162
Exhaled Breath Condensate: Technical and Diagnostic Aspects
Konstantinidi, E. M., Lappas, A. S., Tzortzi, A., & BEHRAKIS, P. K. (2015) · The Scientific World JOURNAL · doi:10.1155/2015/435160 · Cited by 160
Comparative pan-cancer DNA methylation analysis reveals cancer common and specific patterns
Yang, X., Gao, L., & Zhang, S. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw063 · Cited by 158
Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification
Liu, L., Toung, J. M., Jassowicz, A., Vijayaraghavan, R., Kang, H. J., Zhang, R., Kruglyak, K. M., Huang, H. J., Hinoue, T., Shen, H., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy119 · Cited by 154
DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer
Stone, A. M., Zotenko, E., Locke, W. J., Korbie, D. J., Millar, E. K. A., Pidsley, R., Stirzaker, C., Graham, P., Trau, M., Musgrove, E. A., et al. (2015) · Nature Communications · doi:10.1038/ncomms8758 · Cited by 144
Self-citationHypomethylation of Repeated Dna Sequences in Cancer
Ross, J. P., Rand, K. N., & Molloy, P. L. (2010) · Epigenomics · doi:10.2217/epi.10.2 · Cited by 144
Self-citationApplication of liquid biopsy in precision medicine: opportunities and challenges
Wang, J., Chang, S., Li, G., & Sun, Y. (2017) · Frontiers of Medicine · doi:10.1007/s11684-017-0526-7 · Cited by 144
Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy
Gai, W., & Sun, K. (2019) · Genes · doi:10.3390/genes10010032 · Cited by 143
Alvarez, H., Opalinska, J., Zhou, L., Sohal, D. P. S., Fazzari, M. J., Yu, Y., Montagna, C., Montgomery, E. A., Canto, M. I., Dunbar, K. B., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001356 · Cited by 142
Strooper, L. M. A. D., Meijer, C. J. L. M., Berkhof, J. H., Hesselink, A. T., Snijders, P. J. F., Steenbergen, R. D. M., & Heideman, D. A. M. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0237 · Cited by 137
Dietrich, D., Kneip, C., Raji, O., Liloglou, T., Seegebarth, A., Schlegel, T., Flemming, N., Rausch, S., Distler, J., Fleischhacker, M., et al. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1264 · Cited by 136
Pedersen, S. K., Symonds, E. L., Baker, R. T., Murray, D. H., McEvoy, A., van Doorn, S. C., Mundt, M. W., Cole, S. R., Gopalsamy, G. L., Mangira, D., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1674-2 · Cited by 135
Evaluation of commercial kits for purification of circulating free DNA
Diefenbach, R. J., Lee, J., Kefford, R. F., & Rizos, H. (2018) · Cancer Genetics · doi:10.1016/j.cancergen.2018.08.005 · Cited by 133
Payne, S. R. (2010) · Epigenomics · doi:10.2217/epi.10.35 · Cited by 131
UroMark—a urinary biomarker assay for the detection of bladder cancer
Feber, A., Dhami, P., Dong, L., de Winter, P., Tan, W. S., Martínez‐Fernández, M., Paul, D. S., Hynes-Allen, A., Rezaee, S., Gurung, P. M. S., et al. (2017) · Clinical Epigenetics · doi:10.1186/s13148-016-0303-5 · Cited by 131
Strooper, L. M. A. D., Verhoef, V. M. J., Berkhof, J. H., Hesselink, A. T., de Bruin, H. M. E., van Kemenade, F. J., Bosgraaf, R. P., Bekkers, R. L. M., Massuger, L. F. A. G., Melchers, W. J. G., et al. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.02.012 · Cited by 124
D’Andrea, D., Soria, F., Zehetmayer, S., Gust, K. M., Korn, S. M., Witjes, J. A., & Shariat, S. F. (2019) · British Journal of Urology · doi:10.1111/bju.14673 · Cited by 118
Håvik, A. B., Brandal, P., Honne, H., Dahlback, H. S., Scheie, D., Hektoen, M., Meling, T. R., Helseth, E., Heim, S., Lothe, R. A., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-36 · Cited by 114
Schmitz, M., Eichelkraut, K., Schmidt, D., Zeiser, I., Hilal, Z., Tettenborn, Z., Hansel, A., & Ikenberg, H. (2018) · BMC Cancer · doi:10.1186/s12885-018-5125-8 · Cited by 112
Extracellular Nucleic Acids in Urine: Sources, Structure, Diagnostic Potential
Bryzgunova, O. E., & Laktionov, P. P. (2015) · Acta Naturae · doi:10.32607/20758251-2015-7-3-48-54 · Cited by 111
Zhang, C., Yu, W., Wang, L., Zhao, M., Guo, Q., Lv, S., Hu, X., & Lou, J. (2017) · Journal of Cancer · doi:10.7150/jca.21368 · Cited by 111
Considerations on implementing diagnostic markers into clinical decision making in bladder cancer
Lotan, Y., Shariat, S. F., Schmitz‐Dräger, B. J., Sänchez‐Carbayo, M., Jankevičius, F., Racioppi, M., Minner, S. J. P., Stöhr, B., Bassi, P. F., & Grossman, H. B. (2010) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2009.11.004 · Cited by 105
Value-based medicine: concepts and application
Bae, J. M. (2015) · Epidemiology and Health · doi:10.4178/epih/e2015014 · Cited by 105
Su, S., Abreu, A. L., Chihara, Y., Tsai, Y., Andreu‐Vieyra, C., Daneshmand, S., Skinner, E. C., Jones, P. A., Siegmund, K. D., & Liang, G. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2637 · Cited by 105
Neste, L. V., Partin, A. W., Stewart, G. D., Epstein, J. I., Harrison, D. J., & Criekinge, W. V. (2016) · The Prostate · doi:10.1002/pros.23191 · Cited by 105
Fecal DNA testing for Colorectal Cancer Screening: the ColoSure™ test
Ned, R. M., Melillo, S. N., & Marrone, M. T. (2011) · PLoS Currents · doi:10.1371/currents.rrn1220 · Cited by 104
Young, G. P., Pedersen, S. K., Mansfield, S., Murray, D. H., Baker, R. T., Rabbitt, P., Byrne, S. E., Bambacas, L., Hollington, P., & Symonds, E. L. (2016) · Cancer Medicine · doi:10.1002/cam4.868 · Cited by 104
Evaluation of an Epigenetic Profile for the Detection of Bladder Cancer in Patients with Hematuria
van Kessel, K. E. M., Neste, L. V., Lurkin, I., et al. (2015) · The Journal of Urology · doi:10.1016/j.juro.2015.08.085 · Cited by 103
Library-free methylation sequencing with bisulfite padlock probes
Diep, D. H., Plongthongkum, N., Gore, A., Fung, H.-L., Shoemaker, R., & Zhang, K. (2012) · Nature Methods · doi:10.1038/nmeth.1871 · Cited by 103
Symonds, E. L., Pedersen, S. K., Baker, R. T., Murray, D. H., Gaur, S., Cole, S. R., Gopalsamy, G. L., Mangira, D., LaPointe, L. C., & Young, G. P. (2016) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2015.67 · Cited by 99
Population Distribution of Lifetime Risk of Ovarian Cancer in the United States
Pearce, C. L., Stram, D. O., Ness, R. B., Stram, D. A., Roman, L. D., Templeman, C. E., Lee, A. W., Menon, U., Fasching, P. A., McAlpine, J. N., et al. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-1128 · Cited by 98
Hashimoto, K., Kokubun, S., Itoi, E., & Roach, H. I. (2007) · Epigenetics · doi:10.4161/epi.2.2.4203 · Cited by 93
Quantification of Methylated Markers with a Multiplex Methylation-Specific Technology
Zou, H., Allawi, H. T., Cao, X., Domanico, M., Harrington, J. J., Taylor, W. R., Yab, T. C., Ahlquist, D. A., & Lidgard, G. P. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.171264 · Cited by 84
Genomewide bisulfite sequencing reveals the origin and time-dependent fragmentation of urinary cfDNA
Cheng, T. H. T., Jiang, P., Tam, J. C. W., Sun, X., Lee, W., Yu, S. C. Y., Teoh, J. Y., Chiu, P. K., Ng, C., Chow, K. M., et al. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.02.017 · Cited by 82
Blood-Based Protein Biomarker Panel for the Detection of Colorectal Cancer
Fung, K. Y. C., Tabor, B., Buckley, M. J., Priebe, I. K., Purins, L., Pompéia, C., Brierley, G. V., Lockett, T. J., Gibbs, P., Tie, J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120425 · Cited by 81
Self-citationA Two-Gene Blood Test for Methylated DNA Sensitive for Colorectal Cancer
Pedersen, S. K., Baker, R. T., McEvoy, A., Murray, D. H., THOMAS, M. L., Molloy, P. L., Sue, M., Lockett, T. J., Young, G. P., & LaPointe, L. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125041 · Cited by 80
Jelínek, J., Liang, S., Lu, Y., He, R. L., Ramagli, L. S., Shpall, E. J., Estecio, M. R., & Issa, J. J. (2012) · Epigenetics · doi:10.4161/epi.22552 · Cited by 79
Quality Evaluation of Methyl Binding Domain Based Kits for Enrichment DNA-Methylation Sequencing
Meyer, T. D., Mampaey, E., Vlemmix, M., Denil, S. L. I. J., Trooskens, G., Renard, J.-P., Keulenaer, S. D., Dehan, P., Menschaert, G., & Criekinge, W. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059068 · Cited by 77
HPV vaccine impact in Australian women: ready for an HPV‐based screening program
Brotherton, J. M. L., Gertig, D. M., May, C. L., Chappell, G., & Saville, M. (2016) · The Medical Journal of Australia · doi:10.5694/mja15.01038 · Cited by 76
Update on clinical and research application of fecal biomarkers for gastrointestinal diseases
Siddiqui, I., Majid, H., & Abid, S. (2017) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v8.i1.39 · Cited by 69
Lin, S. Y., Linehan, J., Wilson, T. G., & Hoon, D. S. �. (2017) · European Urology Focus · doi:10.1016/j.euf.2017.03.009 · Cited by 68
Switzeny, O. J., Christmann, M., Renovanz, M., Giese, A., Sommer, C., & Kaina, B. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0204-7 · Cited by 67
DNA Stabilization Is Critical for Maximizing Performance of Fecal DNA-Based Colorectal Cancer Tests
Olson, J., Whitney, D. H., Durkee, K. H., & Shuber, A. P. (2005) · Diagnostic Molecular Pathology · doi:10.1097/01.pas.0000176768.18423.7e · Cited by 62
Symonds, E. L., Pedersen, S. K., Murray, D. H., Jedi, M., Byrne, S. E., Rabbitt, P., Baker, R. T., Bastin, D., & Young, G. P. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0500-5 · Cited by 61
Mitchell, S. M., Ho, T., Brown, G. S., Baker, R. T., THOMAS, M. L., McEvoy, A., Xu, Z., Ross, J. P., Lockett, T. J., Young, G. P., et al. (2016) · Genes · doi:10.3390/genes7120125 · Cited by 59
Self-citationMurray, D. H., Symonds, E. L., Young, G. P., Byrne, S. E., Rabbitt, P., Roy, A. C., Cornthwaite, K. J., Karapetis, C. S., & Pedersen, S. K. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2701-x · Cited by 58
COLD-PCR: improving the sensitivity of molecular diagnostics assays
Milbury, C. A., Li, J., Liu, P., & Makrigiorgos, G. M. (2011) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.115 · Cited by 57
Bronchoalveolar Lavage Proteomics in Patients with Suspected Lung Cancer
Carvalho, A. S., Cuco, C., Lavareda, C., Miguel, F. D., Ventura, M., Almeida, S., Pinto, P., de Abreu, T. T., Rodrigues, L. V., Seixas, S., et al. (2017) · Scientific Reports · doi:10.1038/srep42190 · Cited by 57
Klein, E. A., Hubbell, E. A., Maddala, T., Aravanis, A. M., Beausang, J. F., Filippova, D., Gross, S. S., Jamshidi, A., Kurtzman, K. N., Shen, L., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.36.15_suppl.12021 · Cited by 57
Comparative analysis of affinity-based 5-hydroxymethylation enrichment techniques
Thomson, J. P., Hunter, J. M., Nestor, C. E., Dunican, D. S., Terranova, R., Moggs, J. G., & Meehan, R. R. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1080 · Cited by 56
Zhang, J., & Huang, K. (2017) · BMC Genomics · doi:10.1186/s12864-016-3259-0 · Cited by 55
Methylation of P16 in exhaled breath condensate for diagnosis of non-small cell lung cancer
Xiao, P., Chen, J., Chen, J.-R., et al. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.09.008 · Cited by 53
Patient perceptions of stool-based DNA testing for colorectal cancer screening
Schroy, P. C., & Heeren, T. (2005) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2004.10.008 · Cited by 49
Kocsis, A., Takács, T., Jeney, C., Schaff, Z., Koiss, R., Járay, B., Sobel, G., Pap, K., Székely, I., Ferenci, T., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30534 · Cited by 48
Cell-Free DNA in Oncology: Gearing up for Clinic
Ulrich, B. C., & Paweletz, C. P. (2017) · Annals of Laboratory Medicine · doi:10.3343/alm.2018.38.1.1 · Cited by 47
Streleckienė, G., Reid, H. M., Arnold, N., Bauerschlag, D., & Förster, M. (2018) · BioTechniques · doi:10.2144/btn-2018-0003 · Cited by 40
Prada, D., González‐Barrios, R., Sánchez, L., Castro, C., Fabián, E., & Herrera, L. A. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.10.007 · Cited by 39
Evaluation of Methyl-Binding Domain Based Enrichment Approaches Revisited
Åberg, K. A., Xie, L., Chan, R. F., Zhao, M., Pandey, A. K., Kumar, G., Clark, S. L., & van den Oord, E. J. C. G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132205 · Cited by 29
Methylation and Gene Expression of BCAT1 and IKZF1 in Colorectal Cancer Tissues
Jedi, M., Young, G. P., Pedersen, S. K., & Symonds, E. L. (2018) · Clinical Medicine Insights Oncology · doi:10.1177/1179554918775064 · Cited by 29
Rand, K. N., Young, G. P., Ho, T., & Molloy, P. L. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks831 · Cited by 21
Bronchial biopsy specimen as a surrogate for DNA methylation analysis in inoperable lung cancer
Um, S., Kim, H. K., Kim, Y., Lee, B. B., Kim, D., Han, J., Kim, H., Shim, Y. M., & Kim, D.-H. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0432-5 · Cited by 20
DREAM: A Simple Method for DNA Methylation Profiling by High-throughput Sequencing
Jelı́nek, J., & Madžo, J. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-4011-0_10 · Cited by 18
Characterization of Sex-Based Dna Methylation Signatures in the Airways During Early Life
Niño, C. L., Pérez, G. F., Isaza, N. A., Gutierrez, M. J., Gómez, J. L., & Niño, G. (2018) · Scientific Reports · doi:10.1038/s41598-018-23063-5 · Cited by 15
Biomarker patents for diagnostics: problem or solution?
Hopkins, M. M., & Hogarth, S. (2012) · Nature Biotechnology · doi:10.1038/nbt.2257 · Cited by 12
Ross, J. P., Shaw, J. M., & Molloy, P. L. (2012) · Epigenetics · doi:10.4161/epi.23330 · Cited by 7
Self-citationMedical Device Regulatory Practices
Theisz, V. (2015) · doi:10.1201/b18817 · Cited by 6
Cited by
Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA
Luo, H., Wei, W., Ye, Z., Zheng, J., & Xu, R.-H. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.12.011 · Cited by 319
Metadata
- Authors
- Locke, W. J., Guanzon, D., Ma, C., Liew, Y. J., Duesing, K. R., Fung, K. Y. C., & Ross, J. P.
- Venue
- Frontiers in Genetics
- Publisher
- Frontiers Media SA
- Published
- 2019-11-14
- Volume
- 10
- Pages
- 1150-1150
- ISSN
- 1664-8021 (ISSN-L)
- OpenAlex
- W2984827653
- Cited by
- 472
- References
- 152
- FWCI
- 15.76
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.